NCT00118625View on ClinicalTrials.gov

Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

September 30, 2005

Conditions
Type I Hypersensitivity
Interventions
BIOLOGICAL

Tree MATA MPL

Trial Locations (1)

L4W 1N2

Allied Research International Inc., Mississauga

Sponsors
All Listed Sponsors
lead

Allergy Therapeutics

INDUSTRY

NCT00118625 - Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine | Biotech Hunter | Biotech Hunter